Basic Materials / Specialty ChemicalsBSE
$14.43
+0.01 (+0.07%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 10%
FCF escenarios
weak_data · normalized FCF $-3.2M · quality 19.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
25/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$94M
P/E
42.4x
↑EV/EBITDA
30.8x
↑ROE
11.4%
↑Gross Margin
34.0%
↑Debt/Equity
2.64
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-11.7%
FCF CAGR
—
FCF margin
-3.3%
FCF / Net income
-1.45x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $96.7M · net income $2.2M · FCF $-3.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $96.7M | $96.7M | $104.5M | $154.8M | $140.6M |
| Net Income | $2.2M | $2.2M | $-4.9M | $27.6M | $98.0M |
| EBITDA | $4.7M | $4.7M | $-3.6M | $33.8M | $102.5M |
| EPS | 0.34 | 0.34 | -0.76 | 4.24 | 15.06 |
| Gross Margin | 34.0% | 34.0% | 27.4% | 28.0% | 36.2% |
| Operating Margin | 2.5% | 2.5% | -7.6% | 0.1% | -5.6% |
| Net Margin | 2.3% | 2.3% | -4.7% | 17.8% | 69.7% |
| Balance Sheet | |||||
| Debt/Equity | 2.64 | 2.64 | 2.89 | 2.66 | -14.05 |
| Cash Flow | |||||
| Free Cash Flow | $-3.2M | $-3.2M | $5.0M | $-26.3M | $-73.3M |
| Returns | |||||
| ROE | 11.4% | 11.4% | -28.2% | 127.3% | -1795.4% |
| Valuation | |||||
| P/E | 42.44 | 42.44 | — | — | — |
| EV/EBITDA | 30.77 | 30.77 | — | — | — |
| P/B | 4.83 | 4.83 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -7.5% | -7.5% | -32.5% | 10.1% | — |
| EPS Growth | 144.7% | 144.7% | -117.9% | -71.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
55.6%
EPS terminal req.
$1.28
Spread vs growth
89.2%
5Y implied EPS CAGR
35.4%
EPS terminal req.
$1.55
Spread vs growth
109.3%
10Y implied EPS CAGR
22.1%
EPS terminal req.
$2.50
Spread vs growth
122.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-11.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.76 → 0.34
Residual
-11.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.